E-cadherin and alpha-catenin expression in normal, hyperplastic and neoplastic endometrium

Anticancer Research

Volumn 30, Issue 12, 2010, Pages 4993-4998

  Carico, Elisabetta ^a   Atlante, Marco ^b   Giarnieri, Enrico ^a   Raffa, Salvatore ^c   Bucci, Barbara ^d   Giovagnoli, Maria Rosaria ^a   Vecchione, Aldo ^e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Divisione di Ginecologia   (Italy)

^d FATEBENEFRATELLI HOSPITAL   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

; Catenin; Down regulation; E cadherin; Endometrium; Immunohistochemistry

Indexed keywords

ALPHA CATENIN; UVOMORULIN;

ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ALPHA CATENIN; CADHERINS; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; TISSUE DISTRIBUTION;

EID: 78751545491     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Takeichi M: Cadherins in cancer: implication for invasion and metastasis. Curr Opin Cell Biol 5: 806-811, 1993.
2. Shiozaki H, Oka H, Inoue M, Tamura A and Monden M: ECadherin mediated adhesion system in cancer cells. Cancer 77: 1605-1613, 1996.
3. Aplin AE, Howe A, Alahari SK and Juliano RL: Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, Cadherins, immunoglobulin-cell-adhesion molecules, and selectins. Pharmacol Rev 50: 197-263, 1998.
4. Piepenhagen PA and Nelson WJ: Defining E-cadherin associated protein complexes in epithelial cells: plakoglobin, β-catenin and y-catenin are distinct components. J Cell Sci 104: 751-762, 1993.
5. Hinck L, Nathke IS, Papkoff J and Nelson WJ: Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol 125: 1327-1340, 1994.
6. Shimoyama Y, Nagafuchi A, Fujita S, Gotoh M, Takeichi M, Tsukita S and Hirohashi S: Cadherin dysfunction in a human cancer cell line: possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness. Cancer Res 52: 5770-5774,1992.
7. Aberle H, Schwartz H and Kemler R: Cadherin-catenin complex: protein interactions and their implications for Cadherin function. J Cell Biochem 61: 514-523, 1996.
8. Shibamoto S, Hayakawa M, Takeuchi K, Hori T, Miyazawa K, Kitamura N, Johnson KR, Wheelock MJ, Matsuyoshi N, Takeichi M and Ito F: Association of p120, a tyrosine-kinase substrate, with E-cadherin/catenin complexes. J Cell Biol 128: 949-957, 1995.
9. Daniel JM and Reynolds AB: The tyrosine kinase substrate p120cas binds directly to E-cadherin but not to the adenomatous polyposis coli protein , β or, β-catenin. Mol Cell Biol 15: 4819-4824, 1995.
10. Downing JR and Reynolds AB: PDGF, CSF-1 and EGF induce tyrosine phosphorylation of p120, a pp60src transformation substrate. Oncogene 6: 607-613, 1991.
11. Hashimoto M, Niwa O, Nitta Y, Takeichi M and Yokoro K: Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn J Cancer Res 80: 459-463, 1989.
12. Frixen UH, Beherens J, Sachs M, Eberle G, Voss B, Warda A, lochner D and Birchmeier W: E-Cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991.
13. Van Aken E, De Wever O, Correia da Rocha AS and Mareel M: Defective E-cadherin/catenin complexes in human cancer. Virchows Arch 439: 725-751, 2001.
14. Serini G, Trusolino L, Maggiorato E, Cremona O, de Rossi M, Angeli A, Orlandi F and Marchisio PC: Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue. J Natl Cancer Inst 55: 442-449, 1996.
15. Buongiorno PF, al-Kasspooles M, Lee SW, Rachwal WJ, Moore JH, Whyte RI, Orringer MB and Beer DG: E-Cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. Br J Cancer 71: 166-172,1995.
16. Siitonen SM, Kononen JTT, Helin HJ, Rantala IS, Holli KA and Isola JJ: Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 105: 394-402, 1996.
17. Sung-Chul L and Mi-Sook L: Significance of E-cadherin/β-catenin complex and cyclin D1 in breast cancer. Oncol Rep 9: 915-928, 2002.
18. Oka H, H Shiozaki H, Kobayashi K, Tahara H, Tamura S, Miyata M, Doki Y, Iihara K, Mattsuyoshi N and Hirano S: Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch A Pathol Anat Histopathol 421: 149-156, 1992.
19. Weinel RJ, Neumann K, Kisker O and Rosendahl A: Expression and potential role of E-cadherin in pancreatic carcinoma. Int J Pancreatol 19: 25-30, 1996.
20. Wakatsuki S, Watanabe R, Saito K, Katagiri A, Sato S and Tomita Y: Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder. Cancer Lett 103: 11-17, 1996.
21. Cheng L, Nagabhushan M, Pretlow TP, Amini SB and Pretlow TG: Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol 148: 1375-1380, 1996.
22. Danen EH, de Vries TJ, Morandini R, Ghanem GG, Ruiter DJ and van Muijen GN: E-Cadherin expression in human melanoma. Melanoma Res 6: 127-131, 1996.
23. Tohma Y, Yamashima T and Yamashita J: Immunohistochemical localization of cell adhesion molecule epithelial Cadherin in human arachnoid villi and meningiomas. Cancer Res 52: 1981-1987, 1992.
24. Vessey CJ, Wilding J, Folarin N, Hirano S, Takeichi M, Soutter P, Stamp GW and Pignatelli M: Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol 176: 151-159, 1995.
25. Carico E, Atlante M, Bucci B, Nofroni I and Vecchione A: ECadherin and α-catenin expression during tumor progression of cervical epithelium. Gynecol Oncol 80: 156-161, 2001.
26. Carico E, Fulciniti F. Giovagnoli MR, Losito NS, Botti G, Benincasa G, Farnetano MG and Vecchione A: Adhesion molecules and p16 expression in endocervical adenocarcinoma. Virchows Arch 455: 245-251, 2009.
27. Hideyuki N, Tsuyoshi S, Hiroshi Y, Hisanobu M, Eiki I and Ryuichi K: Nuclear localization of α-catenin in normal and carcinogenic endometrium. Mol Carcinog 25: 207-218, 1999.
28. Moreno-Bueno G, Hardisson D, Sarrio D, Sanchez C, Cassia R, Prat J, Herman JG, Esteller M, Matias-Guiu X and Palacios J: Abnormalities of E- and P-cadherin and catenin (beta-, gamma catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia. J Pathol 199: 471-478, 2003.
29. Shih HC, Shiozawa T, Miyamoto T, Kashima H, Feng YZ, Kurai M and Konishi I: Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression. Anticancer Res 24: 3843-3850, 2004.
30. Tsuchiya B, Sato Y, Kameya T, Okayasu I and Mukai K: Differential expression of N-cadherin and E-cadherin in normal human tissues. Arch Histol Cytol 69: 135-145, 2006.
31. Veatch AL, Carson LF and Ramakrishnan S: Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int J Cancer 55: 393-399, 1994.
32. Risinger JI, Berchuck A, Kohler MF and Boyd J: Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet 7: 98-102, 1994.
33. Noyes R, Hertig A and Rock J: Dating the endometrial biopsy. Am J Obstet Gynecol 122: 262-263, 1975.